Dear customers, dear friends,

This DiaLog edition has a clear focus: 30 years of innovation! All topics emphasize DiaSys commitment to new initiatives: Release of Procalcitonin FS and HDL-c direct FS in 2020; launch of SARS CoV-2 UTAB FS antibody test, LDL-c direct FS, and CE marking of our rapid assays for SARS CoV-2 testing in 2021.

Read the full editorial

New reagent for direct determination of LDL-cholesterol

DiaSys is pleased to announce the availability of LDL-c direct FS, a new homogenous assay for direct determination of LDL-cholesterol (LDL-C).

> Read more

Rapid antigen testing in COVID-19: Results within minutes

The rapid test Sugentech SGTi-flex COVID-19 Ag is now CE marked for self-use, approved by TÜV Süd, Germany.

> Read more

30 years anniversary

When a company celebrates its 30th anniversary, it is not necessarily granted that people have been working with the company since the first day.

> Read more

Innovation prize for DiaSys and Fresenius University of Applied Sciences

The state Rhineland-Palatinate awards the 2021 Innovation Prize in the category “cooperation“ for developing a new procalcitonin test using PETIA technology.

> Read more

Member of the IFCC Task Force to manage the COVID-19 pandemic

DiaSys is honored to be part of the IFCC Task Force and will contribute with great commitment to the standardization and optimization of diagnostic tests.

> Read more

Implementation of IVDR scheduled for 2022

DiaSys has recently submitted a written petition to twelve local politicians to support a postponement of the effective date (May 2022) of the IVDR by at least one year.

> Read more

Download DiaLog as PDF

30 Years DiaSys

In 2021, DiaSys celebrates its 30th company anniversary. An 'Inside DiaSys blog' has been established on the website, featuring ongoing articles from staff editors on 'the early days' and global growth.

Read all articles